QQQ   320.26 (+1.45%)
AAPL   164.70 (+1.44%)
MSFT   288.09 (+1.42%)
META   210.62 (+1.34%)
GOOGL   103.22 (+2.31%)
AMZN   103.15 (+1.13%)
TSLA   207.15 (+6.08%)
NVDA   276.60 (+1.01%)
NIO   10.48 (+0.19%)
BABA   102.09 (-1.25%)
AMD   98.03 (+0.15%)
T   19.17 (+0.47%)
F   12.46 (+1.38%)
MU   60.82 (-3.60%)
CGC   1.75 (-0.57%)
GE   95.37 (+1.40%)
DIS   99.63 (+1.56%)
AMC   4.97 (+0.00%)
PFE   40.49 (+0.27%)
PYPL   75.42 (+1.38%)
NFLX   344.91 (+1.91%)
QQQ   320.26 (+1.45%)
AAPL   164.70 (+1.44%)
MSFT   288.09 (+1.42%)
META   210.62 (+1.34%)
GOOGL   103.22 (+2.31%)
AMZN   103.15 (+1.13%)
TSLA   207.15 (+6.08%)
NVDA   276.60 (+1.01%)
NIO   10.48 (+0.19%)
BABA   102.09 (-1.25%)
AMD   98.03 (+0.15%)
T   19.17 (+0.47%)
F   12.46 (+1.38%)
MU   60.82 (-3.60%)
CGC   1.75 (-0.57%)
GE   95.37 (+1.40%)
DIS   99.63 (+1.56%)
AMC   4.97 (+0.00%)
PFE   40.49 (+0.27%)
PYPL   75.42 (+1.38%)
NFLX   344.91 (+1.91%)
QQQ   320.26 (+1.45%)
AAPL   164.70 (+1.44%)
MSFT   288.09 (+1.42%)
META   210.62 (+1.34%)
GOOGL   103.22 (+2.31%)
AMZN   103.15 (+1.13%)
TSLA   207.15 (+6.08%)
NVDA   276.60 (+1.01%)
NIO   10.48 (+0.19%)
BABA   102.09 (-1.25%)
AMD   98.03 (+0.15%)
T   19.17 (+0.47%)
F   12.46 (+1.38%)
MU   60.82 (-3.60%)
CGC   1.75 (-0.57%)
GE   95.37 (+1.40%)
DIS   99.63 (+1.56%)
AMC   4.97 (+0.00%)
PFE   40.49 (+0.27%)
PYPL   75.42 (+1.38%)
NFLX   344.91 (+1.91%)
QQQ   320.26 (+1.45%)
AAPL   164.70 (+1.44%)
MSFT   288.09 (+1.42%)
META   210.62 (+1.34%)
GOOGL   103.22 (+2.31%)
AMZN   103.15 (+1.13%)
TSLA   207.15 (+6.08%)
NVDA   276.60 (+1.01%)
NIO   10.48 (+0.19%)
BABA   102.09 (-1.25%)
AMD   98.03 (+0.15%)
T   19.17 (+0.47%)
F   12.46 (+1.38%)
MU   60.82 (-3.60%)
CGC   1.75 (-0.57%)
GE   95.37 (+1.40%)
DIS   99.63 (+1.56%)
AMC   4.97 (+0.00%)
PFE   40.49 (+0.27%)
PYPL   75.42 (+1.38%)
NFLX   344.91 (+1.91%)
NASDAQ:EKSO

Ekso Bionics - EKSO Stock Forecast, Price & News

$1.65
+0.11 (+7.14%)
(As of 03/31/2023 03:09 PM ET)
Add
Compare
Today's Range
$1.60
$1.66
50-Day Range
$1.35
$1.88
52-Week Range
$1.03
$2.95
Volume
47,006 shs
Average Volume
32,766 shs
Market Capitalization
$21.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Ekso Bionics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
453.8% Upside
$9.00 Price Target
Short Interest
Healthy
0.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.27mentions of Ekso Bionics in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

Medical Sector

655th out of 1,009 stocks

General Industrial Machinery, Industry

4th out of 10 stocks


EKSO stock logo

About Ekso Bionics (NASDAQ:EKSO) Stock

Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Stock News Headlines

Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Medical Robotics Market Updates with Size
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
What Wall Street expects from Ekso Bionics's earnings
Ekso Bionics (EKSO) Set to Announce Earnings on Tuesday
Intelligent Artificial Limb Market Share By 2031
Rehabilitation Robots Market to 2023-2029
See More Headlines
Receive EKSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter.

EKSO Company Calendar

Last Earnings
11/01/2021
Today
3/31/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
General industrial machinery,
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EKSO
Previous Symbol
OTCMKTS:EKSOD
Employees
55
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+484.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,760,000.00
Net Margins
-109.88%
Pretax Margin
-109.88%

Debt

Sales & Book Value

Annual Sales
$11.25 million
Book Value
$2.94 per share

Miscellaneous

Free Float
12,741,000
Market Cap
$20.24 million
Optionable
Not Optionable
Beta
1.75

Key Executives

  • Scott Davis
    President, Chief Executive Officer & Director
  • Jason Jones
    Chief Operating Officer
  • Jerome Wong
    Chief Financial Officer, Secretary & Controller
  • Rino Bevis
    Director-Commercial Health
  • Charlie Wu
    Senior Director-Operations













EKSO Stock - Frequently Asked Questions

Should I buy or sell Ekso Bionics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" EKSO shares.
View EKSO analyst ratings
or view top-rated stocks.

What is Ekso Bionics' stock price forecast for 2023?

1 brokerages have issued 1-year price objectives for Ekso Bionics' shares. Their EKSO share price forecasts range from $9.00 to $9.00. On average, they anticipate the company's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 484.4% from the stock's current price.
View analysts price targets for EKSO
or view top-rated stocks among Wall Street analysts.

How have EKSO shares performed in 2023?

Ekso Bionics' stock was trading at $1.19 at the beginning of the year. Since then, EKSO stock has increased by 29.4% and is now trading at $1.54.
View the best growth stocks for 2023 here
.

When is Ekso Bionics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our EKSO earnings forecast
.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its quarterly earnings data on Monday, November, 1st. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.10. The business earned $3.05 million during the quarter, compared to the consensus estimate of $2.58 million. Ekso Bionics had a negative net margin of 109.88% and a negative trailing twelve-month return on equity of 45.07%. During the same period in the previous year, the business posted ($0.52) earnings per share.

When did Ekso Bionics' stock split?

Ekso Bionics shares reverse split on the morning of Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

What other stocks do shareholders of Ekso Bionics own?
What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Essex Investment Management Co. LLC (3.38%), Legato Capital Management LLC (0.29%), Strategic Wealth Investment Group LLC (0.22%), Simplex Trading LLC (0.00%), Susquehanna International Group LLP (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Jason C Jones, Jerome Wong, John Glenn, Scott G Davis and Steven Sherman.
View institutional ownership trends
.

How do I buy shares of Ekso Bionics?

Shares of EKSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $1.54.

How much money does Ekso Bionics make?

Ekso Bionics (NASDAQ:EKSO) has a market capitalization of $20.24 million and generates $11.25 million in revenue each year. The company earns $-9,760,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The official website for the company is www.eksobionics.com. The company can be reached via phone at (510) 984-1761, via email at investors@eksobionics.com, or via fax at 510-927-2647.

This page (NASDAQ:EKSO) was last updated on 3/31/2023 by MarketBeat.com Staff